| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4023447 | Journal Français d'Ophtalmologie | 2013 | 8 Pages |
Abstract
The physiopathology of IMT is very complex. We have shown that anti-VEGF seems to give satisfactory results for cystoid macular edema in group 1 IMT, although several reinjections may be required. It seems that there is no effective treatment for group 2 IMT without neovascular complications. Future therapeutic progress in the treatment of atrophic age-related macular degeneration will probably be effective in this condition as well.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
F. De Bats, P. Denis, L. Kodjikian,